Cargando…
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1977
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025471/ https://www.ncbi.nlm.nih.gov/pubmed/911666 |
| _version_ | 1782136770621603840 |
|---|---|
| author | McElwain, T. J. Toy, J. Smith, E. Peckham, M. J. Austin, D. E. |
| author_facet | McElwain, T. J. Toy, J. Smith, E. Peckham, M. J. Austin, D. E. |
| author_sort | McElwain, T. J. |
| collection | PubMed |
| description | Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard. |
| format | Text |
| id | pubmed-2025471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1977 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20254712009-09-10 A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. McElwain, T. J. Toy, J. Smith, E. Peckham, M. J. Austin, D. E. Br J Cancer Research Article Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard. Nature Publishing Group 1977-08 /pmc/articles/PMC2025471/ /pubmed/911666 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article McElwain, T. J. Toy, J. Smith, E. Peckham, M. J. Austin, D. E. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title | A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title_full | A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title_fullStr | A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title_full_unstemmed | A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title_short | A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. |
| title_sort | combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of hodgkin's disease. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025471/ https://www.ncbi.nlm.nih.gov/pubmed/911666 |
| work_keys_str_mv | AT mcelwaintj acombinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT toyj acombinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT smithe acombinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT peckhammj acombinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT austinde acombinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT mcelwaintj combinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT toyj combinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT smithe combinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT peckhammj combinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease AT austinde combinationofchlorambucilvinblastineprocarbazineandprednisolonefortreatmentofhodgkinsdisease |